Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.

Nicholas D. James, Noel W. Clarke, William Cross et al.|BORIS (University Library Bern)|2022

Cited by 311